By Aimee Bohn Small cap biotech stocks are giving investors new ways to make big money. Last year was a great opportunity for the biopharma industry. Recent innovations have generated headlines as biotech companies rush to develop COVID-19 vaccines.
There’s an opportunity for big gains in the biotechnology sector. But the industry comes with some risks. If you can stomach high-risk investments with potential for high returns, small cap biotech stocks might be your cup of tea.
Biotech companies are the future of modern medicine. Science advancements are opening doors for treatment and prevention of diseases. These advancements present a unique opportunity for investors.
Chief Income …read more
